Bangladesh is fighting a fast‑moving measles outbreak that has already taken the lives of more than 500 children since March. The World Health Organization and the country’s own Ministry of Health confirm that suspected cases now number in excess of 60 000, a figure that is likely higher as laboratory‑confirmation lags.

The tragedy’s most vivid illustration is the story of Akira, a 4‑year‑old from Dhaka whose family tried four times to get her vaccinated. “Every time at the pharmacy she was turned away – once because of a cold, twice because the shot wasn’t available,” Al Amin tells us, shaking his head. Akira was finally vaccinated on her fifth visit, by which point the measles virus had already ravaged her immune system. She spent 27 days on life‑support before succumbing.

Only 500 of the children who died had been documented as suspected or confirmed cases, suggesting the true toll could be far higher. Hospitals in Dhaka and Cox’s Bazar are teeming with patients, and UNICEF reports that many parents have had to travel to city centres in the hope of finding care that local clinics can’t provide.

The outbreak is not a sudden anomaly. Pre‑pandemic programmes had had families vaccinated in door‑to‑door visits that ceased during COVID‑19. The fear of catching COVID in health facilities left many parents hesitant to seal their children’s health with timely shots.

Political turbulence added another complication. When Sheikh Hassina fled the country amid protests in 2024, an interim government took over. The new leadership changed the vaccine‑procurement process. In multiple meetings, UNICEF warned that such delays would strain the supply chain and “risk an outbreak.” Commentators say the lack of consistent collaboration left a backlog in orders that only began to be addressed after a mass emergency vaccination campaign launched at the beginning of April.

The campaign, backed by international partners, now appears to have plateaued infection rates in its hardest‑hit pockets. Yet the immunity threshold is not immediate; it takes roughly 3–4 weeks for a child to build antibodies. Health Minister Sardar Sakhawat Hossain thus expected a noticeable decline by the following week.

Officials remain cautious, especially with Eid coming up. Dr Mushtaq Husain notes that, “Thousands of children will travel for the holiday, and the mixing of fever‑suffering ones could feed further spread.” Minister Hossain remains confident, dismissing an emergency declaration, saying district hospitals are “ready” and can shoulder the influx.

Al Amin’s grief is palpable. “I give about an hour to the grave each day,” he says in a quiet voice, still counting the days since his daughter fell. He reports the need for sleeping pills, sleepless nights, and an endless internal storm of questions.

The scene on this ‘perfect storm’ of public health: densely packed wards, exhausted nurses, and the hope that a vaccine delivered late chapter will turn the tide. For now, Bangladesh’s battle against measles continues, with a combination of emergency inoculations and a push to rebuild routine immunisation programmes so that no child’s life is lost to missing a vaccine shot again.